Compare Enveric Biosciences Inc (ENVB) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Okta, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Okta, Inc. trades at $151.56 (market cap $26.13B). The key difference: Okta, Inc. is far larger — about 4214.5× Enveric Biosciences Inc's market cap, and Okta, Inc. is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | OKTA | |
|---|---|---|
Market Cap | $6.20M | $26.13B |
Sector | Health | Technology |
52-Week High | $17.40 | $154.62 |
52-Week Low | $1.27 | $62.93 |
Enterprise Value | $1.30M | $23.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
